Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$14.25 - $30.93 $1,638 - $3,556
-115 Closed
0 $0
Q1 2021

Apr 12, 2021

SELL
$10.43 - $17.8 $458 - $783
-44 Reduced 27.67%
115 $2,000
Q2 2020

Jul 20, 2020

BUY
$4.42 - $11.04 $229 - $574
52 Added 48.6%
159 $1,000
Q4 2017

Feb 09, 2018

BUY
$12.12 - $21.65 $1,296 - $2,316
107
107 $2,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $208M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.